As AbbVie Inc. ABBV looks to plug holes in the sales of its mega-blockbuster arthritis drug Humira, newer immunology drugs will be key to the pharmaceutical giant’s future growth, analysts say. When ...
Not only have the Fighting Irish won eight in a row, but all eight have been comfortable, multi-score victories. With a dreadful Syracuse offense coming to town, that kind of performance should be the ...
Hosted on MSN
Coherus Biosciences Divests UDENYCA Business
An update from Coherus Biosciences ( (CHRS)) is now available. On April 11, 2025, Coherus Biosciences sold its UDENYCA business, marking a significant divestiture of its biosimilar businesses, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results